Suchergebnisse - (Person:"De Meyer, Sandra")

PubPharm (7)

1

In Vitro Activity of Simeprevir against Hepatitis C Virus Genotype 1 Clinical Isolates and Its Correlation with NS3 Sequence and Site-Directed Mutants

enthalten in: Antimicrobial agents and chemotherapy | 2015

von Verbinnen, T. | Fevery, B. | Vijgen, L. | +3

2

Virology analyses of HCV isolates from genotype 1-infected patients treated with simeprevir plus peginterferon/ribavirin in Phase IIb/III studies

enthalten in: Journal of hepatology | 2015

von Lenz, O. | Verbinnen, T. | Fevery, B. | +8

3

Evolution of hepatitis C virus quasispecies during repeated treatment with the NS3/4A protease inhibitor telaprevir

enthalten in: Antimicrobial agents and chemotherapy | 2015

von Susser, S. | Flinders, M. | Reesink, H. | +7

4

Prevalence of the hepatitis C virus NS3 polymorphism Q80K in genotype 1 patients in the European region

enthalten in: Antiviral research | 2015

von Sarrazin, C. | Lathouwers, E. | Peeters, M. | +11

5

Deep-sequencing analysis of the gene encoding the hepatitis C virus nonstructural 3-4A protease confirms a low prevalence of telaprevir-resistant variants at baseline and the end of the REALIZE study

enthalten in: The Journal of infectious diseases | 2014

von Dierynck, I. | Thys, K. | Ghys, A. | +5

6

Evolution of treatment-emergent resistant variants in telaprevir phase 3 clinical trials

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2013

von Sullivan, J. | De Meyer, S. | Bartels, D. | +14

7

Hepatitis C virus variants with decreased sensitivity to direct-acting antivirals (DAAs) were rarely observed in DAA-naive patients prior to treatment

enthalten in: Journal of virology | 2013

von Bartels, D. | Sullivan, J. | Zhang, E. | +8

1
[1]